Related Experiment Video
Updated: Jun 20, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Recent advances in glycoconjugate-based therapeutics
1Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, California 94304, USA.
Abstract:
Glycoconjugates are central mediators of molecular recognition in biological systems, yet their inherent structural microheterogeneity has long impeded mechanistic insight and therapeutic translation. Recent advances in synthetic chemistry, chemoenzymatic approaches, and glycoengineering now enable access to structurally defined glycoconjugates, creating new opportunities for precision medicine. Here, we review key developments in glycoconjugate-based therapeutics over the past two years, including glycoconjugate vaccines, glycoengineered peptides and proteins with improved pharmacological properties, glycosite-specific antibody-drug conjugates, glycan-mediated targeted protein degradation, and glycolipid-engineered lipid nanoparticles for nucleic acid delivery. These advances highlight how precise glycan design is transforming glycobiology into a versatile therapeutic platform. Continued integration of synthetic, analytical, and computational strategies is expected to accelerate the development of next-generation glycoconjugate-based medicines.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Glycocalyx and its Functions
Components of...
Microorganisms in Medicine and Therapeutics
Proteoglycans

